- 【ISN-TSN International Conference I】Translational Medicine for Future Nephrology
- Chair:Mai-Szu Wu、Masaomi Nangaku、Chih-Wei Yang、Toshio Miyata
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
15:00 - 15:10 | Opening |
Mai-Szu Wu
|
||
15:10 - 15:35 | 1.Current and future perspectives of telenephrology |
Masaomi Nangaku
|
||
15:36 - 16:00 | 2.Innovative medical device and AI-based software for kidney disease |
Toshio Miyata
|
||
16:00 - 16:25 | 3.What we learn from multi-omics analyses |
Reiko Inagi
|
||
16:30 - 16:45 | 4.From bench to bedside: Immunometabolic regulation for kidney disease |
Huang-Yu Yang
|
||
16:45 - 17:00 | 5.Expanding biotechnology business landscape: industry-academia collaboration |
John Tsung-chun Lee
|
||
17:00 - 17:10 | Panel Discussion | |||
17:10 - 17:15 | Closing |
Mai-Szu Wu
|
- 【ISN-TSN International Conference II】Advances in Kidney Research: Innovative Approaches and Novel Therapies
- Chair:Mai-Szu Wu、Masaomi Nangaku
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
10:35 - 11:00 | 1.New drugs for kidney disease; SGLT2 inhibitor, HIF-PH inhibitor, and beyond |
Masaomi Nangaku
|
||
11:00 - 11:25 | 2.A kidney disease drug helps fight cancer and aging |
Toshio Miyata
|
||
11:25 - 11:50 | 3.Organelle stress in kidney disease |
Reiko Inagi
|
||
11:50 - 12:15 | 4.Pericyte-specific targeting for kidney disease and complication |
Shuei-Liong Lin
|
||
12:15 - 12:25 | Panel Discussion | |||
12:25 - 12:30 | Photo |
- 【Symposium 1】DM, inflammation, uremic toxin management for CVD
- Chair:Horng-Rong Chang、I-Kuan Wang、Wen-Yi Li
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
13:30 - 13:35 | Opening | |||
13:35 - 14:00 | 1.DM, inflammation, uremic toxin management for CVD |
Tsung-Han Tsai
|
||
14:00 - 14:25 | 2.The Gordian knot-- Look into the CardioRenal Metabolic Syndrome |
Wei-Ting Chang
|
||
14:25 - 14:50 | 3.Targeting endothelium in CKD and related CVD |
Fan-Chi Chang
|
||
14:50 - 15:00 | Panel Discussion |
- 【Symposium 2】Controversies in the Therapeutic Management of Volume in AKI Patients
- Chair:Chih-Hsiang Chang、Yu-Feng Lin
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
15:10 - 15:15 | Opening | |||
15:15 - 15:40 | 1.Implementing Green Initiatives in Critical Care: Necessary or Costly? |
Kuo-Hua Lee
|
||
15:40 - 16:05 | 2.Fluid status and fluid responsiveness in AKI patients |
Chia-Chun Lee
|
||
16:05 - 16:30 | 3.Interdisciplinary treatment strategies: Navigating the challenges and opportunities in volume management for cardiovascular and kidney diseases |
Ting-Yu Chiou
|
||
16:30 - 16:40 | Panel Discussion |
- 【腎臟病健康促進機構共學課程】提升腎臟病健康促進機構辦理腎臟病前端防治作業能力
- Chair:蔡宜純
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
09:00 - 09:20 | 早期腎臟病篩選、診斷及轉介 |
蔡宜純
|
||
09:20 - 09:40 | 提升腎臟前端防治能力_院所經驗分享 |
杜柏村
|
||
09:40 - 09:55 | 提升腎臟前端防治能力_院所經驗分享 |
蕭仕敏
|
- 【Advanced CME for CKD nurse】Interdisciplinary care of chronic kidney disease and cardiovascular disease
- Chair:Yi-Chun Tsai
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
13:30 - 14:00 | Experience of case management of heart failure |
Yu-Chen Chung
|
||
14:00 - 14:30 | Team intervention improves the care effectiveness for patients with myocardial infarction – the role of pharmacists |
Shih-Han Wang
|
||
14:30 - 15:00 | The effectiveness of exercise on frailty and sarcopenia in chronic kidney disease |
Hsin-Yi Huang
|
- 【Lunch Symposium 1】Sponsored by:Fresenius Medical Care Taiwan Co., Ltd.
- Chair:Chun-Liang Lin
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
12:30 - 13:20 | How does the HVHDF changes dialysis patient QOL and the clinical application? |
Peter J. Blankestijn
|
- 【Symposium 3】Revisit Peritoneal Dialysis with Modern Mindset
- Chair:Ming-Ju Wu、Chih-Yu Yang
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
15:10 - 15:15 | Opening | |||
15:15 - 15:45 | 1. The role of PD in super-aged society |
Mu-Chi Chung
|
||
15:45 - 16:15 | 2.Elderly patients on PD |
Chieh-Li Yen
|
||
16:15 - 16:25 | Panel Discussion |
- 【Symposium 4】Management of Cardiovascular Diseases in Kidney Transplant Recipients
- Chair:Ping-Chin Lai、Cheng-Hsu Chen
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
09:00 - 09:30 | 1.Medical and intervention therapy of arrhythmia in kidney transplant recipients |
Yu-Cheng Hsieh
|
||
09:30 - 10:00 | 2.Medical and intervention therapy of heart failure in kidney transplant recipients |
Hung-Tien Kuo
|
||
10:00 - 10:30 | 3.Diagnosis and interventional therapy of coronary heart disease in kidney transplant recipients |
Tung-Min Yu
|
- 【Lunch Symposium 2】Sponsored by:AstraZeneca Taiwan Limited
- Chair:Ming-Ju Wu
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
12:30 - 13:20 | Management of complications in CKD: One more think while using reno-protective therapy |
Shang-Feng Tsai
|
- 【Symposium 5】HTN and hyperlipidemic control for CVD
- Chair:Cheng-Hsu Chen、Sheng-Wen Wu、Ping-Fang Chiu
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
13:30 - 13:35 | Opening | |||
13:35 - 14:00 | 1.News about blood pressure and lipid control in managing cardiovascular disease |
C.Y. Wang
|
||
14:00 - 14:25 | 2.Optimizing blood pressure management in chronic kidney disease and diabetes: addressing controversies and evidence gaps |
Edy Kornelius
|
||
14:25 - 14:50 | 3.The neurovascular consequences of cardio-renal syndrome: Exploring the pathways to cognitive impairment and stroke |
Yen-Chung Chen
|
||
14:50 - 15:00 | Panel Discussion |
- Case Communication 1
- Chair:Wen-Chin Lee
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
09:00 - 09:12 | Transplant Renal Artery Stenosis |
謝運芳
徐愷翔
|
||
09:12 - 09:24 | Use of super high-flux hemodialysis,for treatment of HD Patients with Acquired perforating dermatosis |
彭正清
|
||
09:24 - 09:36 | Differential diagnosis consideration between diabetic nephropathy and preeclampsia: a case report |
王昱珩
|
||
09:36 - 09:48 | Disseminated Cryptococcosis Complicating ANCA Associated Vasculitis: A Case Report |
陳維哲
|
||
09:48 - 10:00 | Staphylococcus infection-associated glomerulonephritis in a renal transplant patient |
王偉陵
徐佳鈿
|
||
10:00 - 10:12 | A 23-year-old young woman with de novo thrombotic microangiopathy after ABO incompatible living donor kidney transplantation |
尹玉聰
洪麗玉
廖家德
李明哲
吳美儀
|
||
10:12 - 10:24 | Embolization of bilateral polycystic kidneys as an alternative to pre-transplantation nephrectomy in a patient with recurrent cyst hemorrhage |
李明哲
吳美儀
劉小櫻
呂岳勳
高芷華
|
- 【Lunch Symposium 3】Sponsored by:Novo Nordisk Taiwan
- Chair:Ping-Chin Lai
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
12:30 - 13:20 | The Benefits of Semaglutide to People with Diabetes and Chronic Kidney Disease |
Chih-Chao Yang
|
- Case Communication 2
- Chair:Paik-Seong Lim
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
13:30 - 13:42 | The Details Hidden within Diabetes: Interplay of Albumin-to-Globulin Ratio Reversal in Diabetes Mellitus and IgG4-Related Kidney Disease |
柳向芃
丁瑞聰
巫宏傑
王偉傑
陳冬英
|
||
13:42 - 13:54 | A 36-year-old female with lower urinary symptoms infection and bilateral vesicoureteral reflux |
黃雅琳
陳清揚
|
||
13:54 - 14:06 | Desensitization in a highly sensitized living donor kidney transplant |
徐愷翔
陳宜宏
楊如燁
彭渝森
|
||
14:06 - 14:18 | A case with hemophagocytic lymphohistiocytosis with perirenal tumor suspected aggressive lymphoma |
黃翊安
洪毓權
|
||
14:18 - 14:30 | Pleuroperitoneal communication: A silent killer in peritoneal dialysis patient |
侯順方
|
||
14:30 - 14:42 | A case of cyclosporine-resistant FSGS revealed renal amyloidosis in a second renal biopsy |
徐愷翔
|
||
14:42 - 14:54 | Immune-complex mediated glomerulonephritis secondary to lymphoma |
林佩萱
陳泰迪
陳永昌
田亞中
方基存
楊智偉
塗昆樺
|
||
14:54 - 15:06 | C3 glomerulonephritis with rapid progressive glomerulonephritis |
陳泰迪
陳永昌
田亞中
方基存
楊智偉
塗昆樺
黃怡雯
|
- 【Lunch Symposium 4】Sponsored by:Tai Tien PHARMACEUTICALS Co., Ltd.
- Chair:Cheng-Hsu Chen
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
12:30 - 13:20 | Unlocking Therapeutic Potential of Renal Anemia in Dialysis Patients: Vadadustat, a Novel HIF-PH Inhibitor |
Chia-Lin Wu
|
- 【Lunch Symposium 5】Sponsored by:Eli Lilly and Company (Taiwan)
- Chair:Mai-Szu Wu
Time (UTC+8) | Topic | Speaker | Abstract | |
---|---|---|---|---|
12:30 - 13:20 | Practical guidance for the use of SGLT2 inhibitors in patients with Cardio-Renal-Metabolic disease |
Mu-Chi Chung
|